Follow

Diagonal Bio AB

Nasdaq First North GM (Sweden)

Diagonal Bio is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen – Panviral.

Sector:
HEALTH CARE
IPO
Price
10.50 SEK
Subscription period
10 Jun - 24 Jun 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
DIABIO
SE0015961826
Nasdaq First North GM
Sweden (SE)
Details of share in Diagonal Bio AB with ticker DIABIO
Status
Inactive
Order book id
Amount of instruments
Par value
Currency
SEK
First trading date
06 Jul 2021
Type
Price
Pre-money
Time
Files
IPO
10.50 SEK
56.01M SEK
10 Jun - 24 Jun 2021
IPO in Diagonal Bio AB
People
Jack Egelund-Madsen
CEO
Eva Nilsagård
Chairman of the board
Kerstin Åkesson Jakobsson
Board member
Edvard Hall
Board member
Kushagr Punyani
Board member
Company Details
Sector
HEALTH CARE

Address
Scheelevägen 8
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Registration number
559248-8984
LEI code
9845000469E56665DD98
First trade date
06 Jul 2021
Registration date
19 Mar 2020
Short name
Diagonal

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More